New

Hyperhidrosis Treatment Market

2021

Hyperhidrosis Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Treatment Type (Botulinum Toxin A, Iontophoresis, Surgical Treatments, Topical Treatments, Non-surgical Microwave Energy Destruction of Sweat Glands, Others); Hyperhidrosis Type (Axillary Hyperhidrosis, Palmar Hyperhidrosis, Plantar Hyperhidrosis, Others); End User (Hospitals, Ambulatory Surgical Centers, Others)

| Report Code: TIPRE00011961 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Hyperhidrosis Treatment Market 2028 By Treatment Type, Hyperhidrosis Type, End User | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Hyperhidrosis is abnormally excessive sweating that's not necessarily related to heat or exercise. Hyperhidrosis is a condition that involves excessive sweating. It may affect the whole body or just specific areas. Besides disrupting normal daily activities, this type of heavy sweating can cause social anxiety and embarrassment.

MARKET DYNAMICS

The hyperhidrosis treatment market is driving due to the demand for non-surgical topical treatments, non-surgical microwave energy destruction of sweat glands, and botulinum toxin procedures is rising, owing to benefits such as minimum or no downtime, no wear and tear of skin surface, and minimal side effects. Moreover, the increasing prevalence of axillary hyperhidrosis has been triggering the demand for effective treatments, such as fractional microneedle radiofrequency (FMR) treatment, tap water iontophoresis, and microwave technology.

MARKET SCOPE

The "Hyperhidrosis Treatment Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of hyperhidrosis treatment market with detailed market segmentation by treatment type, hyperhidrosis type and end user. The hyperhidrosis treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in hyperhidrosis treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The hyperhidrosis treatment market is segmented on the basis of treatment type, hyperhidrosis type and end user. Based on treatment type, the market is segmented as botulinum toxin A, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands, and others. On the basis of hyperhidrosis type, the market is categorized as axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis, and others. On the basis of end user, the market is categorized as hospitals, ambulatory surgical centers, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the hyperhidrosis treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hyperhidrosis treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting hyperhidrosis treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hyperhidrosis treatment market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the hyperhidrosis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from hyperhidrosis treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for hyperhidrosis treatment in the global market. Below mentioned is the list of few companies engaged in the hyperhidrosis treatment market.

The report also includes the profiles of key players in hyperhidrosis treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Allergan plc
  •   GlaxoSmithKline plc
  •   Miramar Labs, Inc.
  •   Revance Therapeutics, Inc.
  •   TheraVida, Dermira, Inc.
  •   Ulthera, Inc.


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hyperhidrosis Treatment Market - By Treatment Type
1.3.2 Hyperhidrosis Treatment Market - By Hyperhidrosis Type
1.3.3 Hyperhidrosis Treatment Market - By End User
1.3.4 Hyperhidrosis Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HYPERHIDROSIS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HYPERHIDROSIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HYPERHIDROSIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. HYPERHIDROSIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. HYPERHIDROSIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HYPERHIDROSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. BOTULINUM TOXIN A
7.3.1. Overview
7.3.2. Botulinum Toxin A Market Forecast and Analysis
7.4. IONTOPHORESIS
7.4.1. Overview
7.4.2. Iontophoresis Market Forecast and Analysis
7.5. SURGICAL TREATMENTS
7.5.1. Overview
7.5.2. Surgical Treatments Market Forecast and Analysis
7.6. TOPICAL TREATMENTS
7.6.1. Overview
7.6.2. Topical Treatments Market Forecast and Analysis
7.7. NON-SURGICAL MICROWAVE ENERGY DESTRUCTION OF SWEAT GLANDS
7.7.1. Overview
7.7.2. Non-surgical Microwave Energy Destruction of Sweat Glands Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. HYPERHIDROSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - HYPERHIDROSIS TYPE
8.1. OVERVIEW
8.2. HYPERHIDROSIS TYPE MARKET FORECASTS AND ANALYSIS
8.3. AXILLARY HYPERHIDROSIS
8.3.1. Overview
8.3.2. Axillary Hyperhidrosis Market Forecast and Analysis
8.4. PALMAR HYPERHIDROSIS
8.4.1. Overview
8.4.2. Palmar Hyperhidrosis Market Forecast and Analysis
8.5. PLANTAR HYPERHIDROSIS
8.5.1. Overview
8.5.2. Plantar Hyperhidrosis Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. HYPERHIDROSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. AMBULATORY SURGICAL CENTERS
9.4.1. Overview
9.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. HYPERHIDROSIS TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Hyperhidrosis Treatment Market Overview
10.1.2 North America Hyperhidrosis Treatment Market Forecasts and Analysis
10.1.3 North America Hyperhidrosis Treatment Market Forecasts and Analysis - By Treatment Type
10.1.4 North America Hyperhidrosis Treatment Market Forecasts and Analysis - By Hyperhidrosis Type
10.1.5 North America Hyperhidrosis Treatment Market Forecasts and Analysis - By End User
10.1.6 North America Hyperhidrosis Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Hyperhidrosis Treatment Market
10.1.6.1.1 United States Hyperhidrosis Treatment Market by Treatment Type
10.1.6.1.2 United States Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.1.6.1.3 United States Hyperhidrosis Treatment Market by End User
10.1.6.2 Canada Hyperhidrosis Treatment Market
10.1.6.2.1 Canada Hyperhidrosis Treatment Market by Treatment Type
10.1.6.2.2 Canada Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.1.6.2.3 Canada Hyperhidrosis Treatment Market by End User
10.1.6.3 Mexico Hyperhidrosis Treatment Market
10.1.6.3.1 Mexico Hyperhidrosis Treatment Market by Treatment Type
10.1.6.3.2 Mexico Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.1.6.3.3 Mexico Hyperhidrosis Treatment Market by End User
10.2. EUROPE
10.2.1 Europe Hyperhidrosis Treatment Market Overview
10.2.2 Europe Hyperhidrosis Treatment Market Forecasts and Analysis
10.2.3 Europe Hyperhidrosis Treatment Market Forecasts and Analysis - By Treatment Type
10.2.4 Europe Hyperhidrosis Treatment Market Forecasts and Analysis - By Hyperhidrosis Type
10.2.5 Europe Hyperhidrosis Treatment Market Forecasts and Analysis - By End User
10.2.6 Europe Hyperhidrosis Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Hyperhidrosis Treatment Market
10.2.6.1.1 Germany Hyperhidrosis Treatment Market by Treatment Type
10.2.6.1.2 Germany Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.2.6.1.3 Germany Hyperhidrosis Treatment Market by End User
10.2.6.2 France Hyperhidrosis Treatment Market
10.2.6.2.1 France Hyperhidrosis Treatment Market by Treatment Type
10.2.6.2.2 France Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.2.6.2.3 France Hyperhidrosis Treatment Market by End User
10.2.6.3 Italy Hyperhidrosis Treatment Market
10.2.6.3.1 Italy Hyperhidrosis Treatment Market by Treatment Type
10.2.6.3.2 Italy Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.2.6.3.3 Italy Hyperhidrosis Treatment Market by End User
10.2.6.4 Spain Hyperhidrosis Treatment Market
10.2.6.4.1 Spain Hyperhidrosis Treatment Market by Treatment Type
10.2.6.4.2 Spain Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.2.6.4.3 Spain Hyperhidrosis Treatment Market by End User
10.2.6.5 United Kingdom Hyperhidrosis Treatment Market
10.2.6.5.1 United Kingdom Hyperhidrosis Treatment Market by Treatment Type
10.2.6.5.2 United Kingdom Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.2.6.5.3 United Kingdom Hyperhidrosis Treatment Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Hyperhidrosis Treatment Market Overview
10.3.2 Asia-Pacific Hyperhidrosis Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Hyperhidrosis Treatment Market Forecasts and Analysis - By Treatment Type
10.3.4 Asia-Pacific Hyperhidrosis Treatment Market Forecasts and Analysis - By Hyperhidrosis Type
10.3.5 Asia-Pacific Hyperhidrosis Treatment Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Hyperhidrosis Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Hyperhidrosis Treatment Market
10.3.6.1.1 Australia Hyperhidrosis Treatment Market by Treatment Type
10.3.6.1.2 Australia Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.3.6.1.3 Australia Hyperhidrosis Treatment Market by End User
10.3.6.2 China Hyperhidrosis Treatment Market
10.3.6.2.1 China Hyperhidrosis Treatment Market by Treatment Type
10.3.6.2.2 China Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.3.6.2.3 China Hyperhidrosis Treatment Market by End User
10.3.6.3 India Hyperhidrosis Treatment Market
10.3.6.3.1 India Hyperhidrosis Treatment Market by Treatment Type
10.3.6.3.2 India Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.3.6.3.3 India Hyperhidrosis Treatment Market by End User
10.3.6.4 Japan Hyperhidrosis Treatment Market
10.3.6.4.1 Japan Hyperhidrosis Treatment Market by Treatment Type
10.3.6.4.2 Japan Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.3.6.4.3 Japan Hyperhidrosis Treatment Market by End User
10.3.6.5 South Korea Hyperhidrosis Treatment Market
10.3.6.5.1 South Korea Hyperhidrosis Treatment Market by Treatment Type
10.3.6.5.2 South Korea Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.3.6.5.3 South Korea Hyperhidrosis Treatment Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Hyperhidrosis Treatment Market Overview
10.4.2 Middle East and Africa Hyperhidrosis Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Hyperhidrosis Treatment Market Forecasts and Analysis - By Treatment Type
10.4.4 Middle East and Africa Hyperhidrosis Treatment Market Forecasts and Analysis - By Hyperhidrosis Type
10.4.5 Middle East and Africa Hyperhidrosis Treatment Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Hyperhidrosis Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Hyperhidrosis Treatment Market
10.4.6.1.1 South Africa Hyperhidrosis Treatment Market by Treatment Type
10.4.6.1.2 South Africa Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.4.6.1.3 South Africa Hyperhidrosis Treatment Market by End User
10.4.6.2 Saudi Arabia Hyperhidrosis Treatment Market
10.4.6.2.1 Saudi Arabia Hyperhidrosis Treatment Market by Treatment Type
10.4.6.2.2 Saudi Arabia Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.4.6.2.3 Saudi Arabia Hyperhidrosis Treatment Market by End User
10.4.6.3 U.A.E Hyperhidrosis Treatment Market
10.4.6.3.1 U.A.E Hyperhidrosis Treatment Market by Treatment Type
10.4.6.3.2 U.A.E Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.4.6.3.3 U.A.E Hyperhidrosis Treatment Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Hyperhidrosis Treatment Market Overview
10.5.2 South and Central America Hyperhidrosis Treatment Market Forecasts and Analysis
10.5.3 South and Central America Hyperhidrosis Treatment Market Forecasts and Analysis - By Treatment Type
10.5.4 South and Central America Hyperhidrosis Treatment Market Forecasts and Analysis - By Hyperhidrosis Type
10.5.5 South and Central America Hyperhidrosis Treatment Market Forecasts and Analysis - By End User
10.5.6 South and Central America Hyperhidrosis Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Hyperhidrosis Treatment Market
10.5.6.1.1 Brazil Hyperhidrosis Treatment Market by Treatment Type
10.5.6.1.2 Brazil Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.5.6.1.3 Brazil Hyperhidrosis Treatment Market by End User
10.5.6.2 Argentina Hyperhidrosis Treatment Market
10.5.6.2.1 Argentina Hyperhidrosis Treatment Market by Treatment Type
10.5.6.2.2 Argentina Hyperhidrosis Treatment Market by Hyperhidrosis Type
10.5.6.2.3 Argentina Hyperhidrosis Treatment Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HYPERHIDROSIS TREATMENT MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. HYPERHIDROSIS TREATMENT MARKET, KEY COMPANY PROFILES
13.1. ALLERGAN PLC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GLAXOSMITHKLINE PLC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. MIRAMAR LABS, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. REVANCE THERAPEUTICS, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. THERAVIDA, DERMIRA, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ULTHERA, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Allergan plc
2. GlaxoSmithKline plc
3. Miramar Labs, Inc.
4. Revance Therapeutics, Inc.
5. TheraVida, Dermira, Inc.
6. Ulthera, Inc.
TIPRE00011961
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.